Skip to main content
Clinical Trials/NCT01768416
NCT01768416
Completed
Not Applicable

Measuring Depth of Unconsciousness at the End of Life: the Reliability of the BIS Monitoring as an Assessment Tool Versus Sedation Scales

University Hospital, Ghent1 site in 1 country10 target enrollmentMarch 1, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Loss of Consciousness at End of Life
Sponsor
University Hospital, Ghent
Enrollment
10
Locations
1
Primary Endpoint
Measuring the accuracy of BIS monitoring in assessing the evolution of the level of consciousness in pre-terminal patients
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to use the BIS monitor to assess the degree of consciousness in pre-terminal palliative patients admitted to our palliative care unit and to ascertain if this tool provides a more accurate assessment of consciousness in this specific group of patients than clinical observation of consciousness and the use of sedation scales.

We hypothesize that the measured BIS results provide a more accurate assessment of the patient's level of consciousness than routine clinical observation or the use of sedation scales.

Registry
clinicaltrials.gov
Start Date
March 1, 2013
End Date
September 23, 2015
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pre-terminal palliative patients with a life expectancy of 72 hours or less at the start of the observation.

Exclusion Criteria

  • lack of consent of patient or representative

Outcomes

Primary Outcomes

Measuring the accuracy of BIS monitoring in assessing the evolution of the level of consciousness in pre-terminal patients

Time Frame: 72 hours

Measuring the accuracy of BIS monitoring in assessing the evolution of the level of consciousness in pre-terminal patients with a life expectancy of 72 hours or less from the moment of the first clinical signs of dying and loss of consciousness until the moment of death.

Secondary Outcomes

  • Determining the evolution of BIS values, measured in pre-terminal patients(72 hours)

Study Sites (1)

Loading locations...

Similar Trials